EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Drug screens using the nematode Caenorhabditis elegans

Peter J Roy iD

GENETICS · 03.09.2025 · 231 (1)

DOI: 10.1093/genetics/iyaf141 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift GENETICS, online erschienen am 12.08.2025. Verfasst von Peter J Roy. Beteiligte Einrichtung: Department of Molecular Genetics, University of Toronto, 1 King's College Circle, Toronto, Ontario M5S 1A8, Canada. Hauptthemen laut MEDLINE: Caenorhabditis elegans, Drug Discovery. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 182 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Canada Research Chairs Program, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since its inception as a model system, Caenorhabditis elegans has provided insight about the mechanism of action of drugs through genetic analyses. With the arrival of diverse drug-like small molecule libraries sometime later, the worm also became a platform for drug discovery that was previously inaccessible to academics. Here, the history of larger-scale drug screens using C. elegans is reviewed. The current approaches used to identify the targets and targeted pathways of the novel hits from these screens are also discussed. We focus on the development of small molecule tools for biological investigation, the discovery of novel candidate nematicides and anthelmintics, and touch on screens related to other areas of biology, including neurodegeneration. Finally, we draw attention to the fundamental aspects of C. elegans biology that lends itself to chemical genetic research. When combined with diverse small molecule libraries, the worm's tractability and genetic power make it an unparalleled whole-animal model system for early-stage drug discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Caenorhabditis elegansDrug DiscoveryAnimalsSmall Molecule LibrariesDrug Evaluation, PreclinicalAnthelminticsAntinematodal Agents

Stichwörter der Autor:innen

Caenorhabditis elegansWormBaseanthelminticscompoundsdrug screensdrugsgenetic suppressionnematicidesreviewsmall molecule

Substanzen

Small Molecule LibrariesAnthelminticsAntinematodal Agents

Autor:innen und Institutionen

  • Department of Molecular Genetics, University of Toronto, 1 King's College Circle, Toronto, Ontario M5S 1A8, Canada.
  • Terrence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, 160 College St., Toronto, Ontario M5S 3E1, Canada.
  • Department of Pharmacology and Toxicology, University of Toronto, 1 King's College Circle, Toronto, Ontario M5S 1A8, Canada.

ORCID-Profile: Peter J Roy

Förderung

  • CIHR
  • Canada Research Chairs Program
  • Canadian Institutes of Health Research

Zitieren

APA

Roy, P. J. (2025). Drug screens using the nematode Caenorhabditis elegans. GENETICS, 231(1). https://doi.org/10.1093/genetics/iyaf141

Vancouver

Roy PJ. Drug screens using the nematode Caenorhabditis elegans. GENETICS. 2025;231(1). doi:10.1093/genetics/iyaf141

BibTeX
@article{Roy2025,
  author = {Roy, Peter J},
  title = {Drug screens using the nematode Caenorhabditis elegans},
  journal = {GENETICS},
  year = {2025},
  volume = {231},
  number = {1},
  doi = {10.1093/genetics/iyaf141}
}
Kostenlos starten →